Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
New vaccine technology tested to better protect vulnerable transplant patients from COVID-19
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new type of COVID-19 vaccine designed to work better in people who have received a blood or marrow transplant. It compares this experimental vaccine, called LUNAR-COV19, to the approved Pfizer Comirnaty vaccine. The goal is to see if the new vaccine is saf…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:42 UTC
-
Computer decides cancer treatment: will patients trust the flip of a coin?
Disease control Not yet recruitingThis study aims to find out if adults with acute myeloid leukemia (AML) who are considered less medically fit are willing to let a computer randomly assign them to either higher or lower intensity chemotherapy. The goal is to determine which treatment intensity works best for thi…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 22:11 UTC
-
Targeted radiation 'Warhead' tested in fight against Tough-to-Treat blood cancer
Disease control Not yet recruitingThis early-stage trial is testing a new, targeted radiation treatment for patients with high-risk multiple myeloma. The treatment involves an antibody that seeks out cancer cells and delivers a radioactive substance directly to them. This is given before a donor stem cell transpl…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI chatbot vs. text messages: new tech battle to help native communities kick smoking habit
Disease control Not yet recruitingThis study is testing two smartphone-based programs to help American Indian and Alaska Native adults quit smoking. Researchers want to see if a daily AI chatbot or standard text messages are more effective at providing support and motivation over a 42-day quit program. The goal i…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Double the probes, double the protection? new hope for cervical cancer prevention in High-Risk women
Disease control Not yet recruitingThis study is testing if using two heat probes instead of one is a better way to treat early cervical changes and prevent cancer in women living with HIV. It will involve 300 women in Rwanda who have tested positive for HPV or a visual exam. The main goal is to see if the two-pro…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Double attack on tough blood cancer: pill plus supercharged immune cells
Disease control Not yet recruitingThis study is testing if adding a daily pill called nemtabrutinib makes a personalized cell therapy more effective for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to other treatments. The cell therapy,…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Free nicotine patches sent to phones: can an app double quit rates?
Disease control Not yet recruitingThis study aims to see if adding free nicotine patches and gum to a smartphone quit-smoking app helps Hispanic adults quit cigarettes better than the app alone. About 850 participants will use the iCanQuit app for a year; half will also receive nicotine replacement therapy delive…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can your phone help you quit vaping? new app trial aims to find out
Disease control Not yet recruitingThis study is testing a smartphone app designed to help young adults quit vaping and using all nicotine products. Over 1,300 participants will use one of two versions of the app, which teaches skills to manage cravings and triggers for tobacco use. The main goal is to see if the …
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope for Tough-to-Treat lymphoma: experimental transplant approach
Disease control Not yet recruitingThis study is testing a new treatment approach for adults whose T-cell lymphoma has returned or hasn't responded to previous therapies. It combines two chemotherapy drugs (pralatrexate and bendamustine) with low-dose total body radiation, followed by a stem cell transplant from a…
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New program aims to boost Life-Saving lung cancer checks in native communities
Prevention Not yet recruitingThis study is testing a support program to help more people in tribal communities in Washington state get screened for lung cancer. Researchers want to see if a tailored patient navigation service, which guides people through the healthcare system, helps more eligible individuals…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Apr 01, 2026 22:11 UTC
-
New program aims to boost Life-Saving lung cancer checks in black communities
Prevention Not yet recruitingThis study is testing a new community program designed to help Black individuals make informed decisions about lung cancer screening. The program uses restorative justice principles to build trust and address health inequalities. Researchers want to see if this approach increases…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Apr 01, 2026 22:11 UTC
-
Can better pharmacy chats stop future cancers?
Prevention Not yet recruitingThis study aims to increase HPV vaccination rates in children by testing new training programs for pharmacy staff. It will compare usual care to training that teaches staff how to strongly recommend vaccines and manage the vaccination process. The goal is to see if these approach…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Mar 25, 2026 14:07 UTC
-
Double the probes, double the protection? new study aims to boost cervical cancer prevention for women with HIV
Prevention Not yet recruitingThis study is testing if using two heat probes instead of one is a better way to treat precancerous cervical cells in women living with HIV, who are at much higher risk for cervical cancer. Researchers in Kenya will compare the two approaches in 300 women to see which one is more…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Mar 17, 2026 13:09 UTC
-
Phone coaching aims to ease tough cancer care conversations
Symptom relief Not yet recruitingThis study is testing a phone-based coaching program called 'Talking About Cancer' to help patients with advanced cancer and their support person plan for future medical care. The goal is to see if these coaching sessions make it easier to have important conversations about treat…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Can a website ease the harsh side effects of breast cancer chemo?
Symptom relief Not yet recruitingThis study is testing whether an online nutrition education program can help people with breast cancer better manage common and uncomfortable side effects of chemotherapy, like diarrhea and constipation. It will compare standard care to standard care plus access to a special webs…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Cash for cancer patients: can money ease treatment stress?
Symptom relief Not yet recruitingThis study is testing if giving monthly cash payments to early-stage cancer patients who are worried about money can help them. The goal is to see if this extra financial support makes it easier for patients to pay for basics like food and rent, which might help them stick to the…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC